January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21. The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]
04
Jan
Jan
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]
31
Dec
Dec
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]
29
Dec
Dec
This past year has been one of uncertainty and many people’s lives have changed drastically over the course of nine months. While maintaining social distancing and stay at home orders, routine health has taken a back seat to protecting ourselves and each other from infection. As we wrap up the holidays and enter into a […]
10
Dec
Dec
Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec. 10, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that it is providing BioReference Laboratories, Inc., an OPKO Health company and a leading provider of laboratory testing services in the U.S., with […]
03
Dec
Dec
We are excited to announce that BioReference Laboratories now supports test results through Health Records on iPhone in the Apple Health app.* The Health Records feature makes it easy to see a central view of your health records from multiple providers whenever you choose, including your lab results. Getting your BioReference test results into your […]
10
Nov
Nov
The leaves are falling, there is a cold crisp in the air, and the smell of pumpkin spice fills local markets. Concurrently, the sniffles and coughing have started and you may feel a tingle in your throat or have spiked a fever. Cold and flu season is upon us yet again; but this year, with […]
20
Oct
Oct
New offering identifies COVID-19 and Influenza infections with a single sample ELMWOOD PARK, N.J., October 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the […]
09
Oct
Oct
Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools ELMWOOD PARK, N.J., October 9, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school […]
Mad Money with Jim Cramer BioReference Laboratories Executive Chairman Jon Cohen gives an update on coronavirus testing in the NBA and NFL, clearing the air behind so-called “false positive” diagnoses in football. Click here for original post on Mad Money with Jim Cramer
